For IPO Boutique's "scale of 1 to 5" BUY rating on Iroko Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
About Iroko Pharmaceuticals (adapted from Iroko Pharmaceuticals prospectus): They are a global, specialty pharmaceutical company focused on the development and commercialization of novel nonsteroidal anti-inflammatory drug therapeutics for patients with mild to moderate acute and chronic pain.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "IRKO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?